sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks N-Methylsuccinimide

N-Methylsuccinimide

CAS No.:
1121-07-9
Catalog Number:
AG0035EN
Molecular Formula:
C5H7NO2
Molecular Weight:
113.1146
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
95%
In Stock USA
United States
$63
- +
25g
95%
In Stock USA
United States
$204
- +
Product Description
Catalog Number:
AG0035EN
Chemical Name:
N-Methylsuccinimide
CAS Number:
1121-07-9
Molecular Formula:
C5H7NO2
Molecular Weight:
113.1146
MDL Number:
MFCD00005517
IUPAC Name:
1-methylpyrrolidine-2,5-dione
InChI:
InChI=1S/C5H7NO2/c1-6-4(7)2-3-5(6)8/h2-3H2,1H3
InChI Key:
KYEACNNYFNZCST-UHFFFAOYSA-N
SMILES:
CN1C(=O)CCC1=O
NSC Number:
11324
Properties
Complexity:
125  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
113.048g/mol
Formal Charge:
0
Heavy Atom Count:
8  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
113.116g/mol
Monoisotopic Mass:
113.048g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
37.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.9  
Literature
Title Journal
Embryotoxic potential of N-methyl-pyrrolidone (NMP) and three of its metabolites using the rat whole embryo culture system. Toxicology and applied pharmacology 20090601
Lymphocyte recruitment into the tumor site is altered in patients with MSI-H colon cancer. Familial cancer 20090101
Comparative developmental toxicities of the three major metabolites of N-methyl-2-pyrrolidone after oral administration in rats. Journal of applied toxicology : JAT 20070101
K-ras, p53 mutations, and microsatellite instability (MSI) in gallbladder cancer. Journal of surgical oncology 20060615
Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy- N-methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy- N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker. International archives of occupational and environmental health 20030501
Acylating agents as enzyme inhibitors and understanding their reactivity for drug design. Journal of medicinal chemistry 20020620
N-methylsuccinimide in plasma and urine as a biomarker of exposure to N-methyl-2-pyrrolidone. International archives of occupational and environmental health 20010501
Properties